Tag: grazoprevir + elbasvir

Pacific Hep C Network – Patient Input Surveys

The Canadian Agency for Drugs and Technologies in Health (CADTH) wants to hear from you! They are currently seeking patient input for grazoprevir / elbasvir and, therefore, the Pacific Hep C Network (PHCN) needs your thoughts, opinions, and experiences for our patient group input report. There are two PHCN Input Surveys Take this survey if… Read more »

CATIE Treatment Update 208

In this issue: HEPATITIS C VIRUS Grazoprevir + elbasvir and other emerging drugs Enter ledipasvir Sirius—ledipasvir + sofosbuvir in cases of severe liver injury Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed Grading severe liver disease and predicting survival Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants Solar-1—ledipasvir +… Read more »